High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India.

Tony, Ann Maria; Vinod, Vivek; Nambiar, Vivek; Krishnan, Sajitha; Biswas, Lalitha

Tony, Ann Maria; Vinod, Vivek; Nambiar, Vivek; Krishnan, Sajitha; Biswas, Lalitha.

Afiliação

Tony AM; Centre for Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
Vinod V; Centre for Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
Nambiar V; Department of Stroke Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
Krishnan S; Department of Biochemistry, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
Biswas L; Centre for Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.

Hamostaseologie ; 43(2): 126-131, 2023 Apr.

Article em En | MEDLINE | ID: mdl-35255511

Assuntos

Tromboembolia Venosa; Humanos; Adulto; Tromboembolia Venosa/epidemiologia; Tromboembolia Venosa/genética; Estudos de Casos e Controles; Inibidor 1 de Ativador de Plasminogênio/genética; Protrombina/genética; Prevalência

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Hamostaseologie Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google